03/25/2024
4:58 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
6:06 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
6:17 PM | Chung Christine (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
6:18 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
6:19 PM | FibroGen (Issuer)
Graham Juan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
7:33 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
7:28 PM | FibroGen (Issuer)
Graham Juan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
02/23/2024
7:29 PM | Chung Christine (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
2:37 PM | ARMISTICE CAPITAL, LLC (Filed by)
FibroGen (Subject)
| Form SC 13G | |
02/05/2024
7:08 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
6:28 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
3:19 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
3:20 PM | Chung Christine (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
3:21 PM | FibroGen (Issuer)
Graham Juan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2023
3:05 PM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
3:11 PM | FibroGen (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/27/2023
3:30 PM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/05/2023
6:41 PM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2023
6:37 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
7:54 PM | FibroGen (Issuer)
Henderson Jeffrey William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
7:55 PM | Eisner Mark (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
7:55 AM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/01/2023
6:37 PM | Chung Christine (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/01/2023
6:38 PM | FibroGen (Issuer)
Graham Juan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/01/2023
4:31 PM | FibroGen (Subject)
Henderson Jeffrey William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2023
4:14 PM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2023
4:28 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2023
6:10 PM | FibroGen (Issuer)
Henderson Jeffrey William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/04/2023
3:42 PM | FibroGen (Subject)
Henderson Jeffrey William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/25/2023
7:32 AM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2023
3:47 PM | FibroGen (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G | |
07/19/2023
6:01 AM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/13/2023
7:28 PM | FibroGen (Issuer)
Henderson Jeffrey William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2023
3:46 PM | FibroGen (Subject)
Henderson Jeffrey William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2023
6:36 PM | Conterno Enrique A (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
3:27 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
8:05 AM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2023
8:53 PM | FibroGen (Subject)
Wettig Thane (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/22/2023
5:32 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4/A | |
06/15/2023
7:17 PM | Chung Christine (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
5:15 PM | Chung Christine (Reporting)
FibroGen (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad) AI was by far the biggest tech investing trend right now.
But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple.
Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now…
And could soon shoot to the moon, handing early investors a windfall. Click here now for the full details of this stock that’s set to rocket in the AI revolution… |
06/09/2023
6:52 PM | FibroGen (Issuer)
Henderson Jeffrey William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:53 PM | EDWARDS JEFFREY L (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:53 PM | FibroGen (Issuer)
Lema Gerald (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:54 PM | FibroGen (Issuer)
Ho Maykin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:54 PM | Blaug Suzanne (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:55 PM | Brennan Aoife (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:56 PM | Cravatt Benjamin (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
7:10 PM | Cravatt Benjamin (Reporting)
FibroGen (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/09/2023
7:11 PM | EDWARDS JEFFREY L (Reporting)
FibroGen (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/09/2023
7:14 PM | Blaug Suzanne (Reporting)
FibroGen (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/09/2023
7:17 PM | Brennan Aoife (Reporting)
FibroGen (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/09/2023
6:51 PM | FibroGen (Issuer)
Schoeneck James A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:38 PM | Chung Christine (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:39 PM | FibroGen (Issuer)
Graham Juan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:39 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:10 PM | Conterno Enrique A (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:12 PM | Eisner Mark (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
6:49 PM | FibroGen (Subject)
Graham Juan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/08/2023
4:51 PM | FibroGen (Subject)
Ho Maykin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/08/2023
4:51 PM | FibroGen (Subject)
Henderson Jeffrey William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023
8:51 PM | FibroGen (Subject)
Graham Juan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023
8:31 PM | Chung Christine (Reporting)
FibroGen (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023
8:36 PM | Eisner Mark (Reporting)
FibroGen (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023
8:41 PM | FibroGen (Subject)
Wettig Thane (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023
9:34 AM | FibroGen (Subject)
Schoeneck James A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023
8:00 AM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/02/2023
7:53 PM | Eisner Mark (Reporting)
FibroGen (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2023
8:00 AM | FibroGen (Filer)
| Form DEFA14A | |
05/18/2023
6:35 AM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
